Allonnia Launches with $40M in Series A Funding

Allonnia LLC, a Boston, MA-based bioremediation company focused on waste management, launched with $40m in Series A funding.

Backers included Ginkgo Bioworks, Battelle, General Atlantic, Cascade Investment, and Viking Global Investors. Allonnia is the first company to launch from the Ferment Consortium, Ginkgo Bioworks’ investment vehicle for leveraging synthetic biology to solve global challenges and transform established industries.

Through advanced technologies and progressive biology, the company will engineer innovative systems to develop and commercialize new waste remediation and management solutions. The company will tackle some of the planet’s most pressing waste pollution challenges, including industrial wastewater treatment, soil remediation, and solid waste management and upcycling.

One of the company’s first areas of focus will be on per- and poly-fluorinated compounds including PFAS, PFOA, and PFOS. These compounds are known as “forever chemicals” because they do not degrade and can persist in the environment for decades, contaminating soil and ground water and even making their way into human bloodstreams.

Allonnia will be spearheaded by Nicole Richards, joining as CEO (effective immediately). She brings over 28 years of industry experience leading business strategy, sales, and marketing initiatives within water treatment, mining and industrial chemicals, pharmaceuticals, and more. Most recently, she served as Growth, Strategy and M&A Director—Water Solutions at DuPont. Prior to that, she served as Global Director at Solvay, a science company focused on developing sustainability solutions within materials, chemicals, and solutions.



Join the discussion